Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13427082 | 0.98 | CTDSP1 (0.32) | CTDSP1PDK2PGR | |
| SCHEMBL13008234 | 0.98 | CTDSP1 (0.32) | CTDSP1PDK2PGR | |
| SCHEMBL13008788 | 0.97 | CTDSP1 (0.33) | CTDSP1PDK2PGRTNKS | |
| SCHEMBL13009397 | 0.97 | CTDSP1 (0.33) | CTDSP1PDK2PGRTNKS | |
| SCHEMBL13427074 | 0.96 | CTDSP1 (0.32) | CTDSP1PDK2PGRTNKS | |
| SCHEMBL13428145 | 0.94 | HSD17B3 (0.34) | PDK2PGR | |
| SCHEMBL13426928 | 0.94 | CTDSP1 (0.32) | CTDSP1PGRTNKS | |
| SCHEMBL13009392 | 0.94 | CTDSP1 (0.32) | CTDSP1PGRTNKS | |
| SCHEMBL13427005 | 0.93 | MET (0.32) | — | |
| SCHEMBL13427081 | 0.93 | MET (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2256176-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2010-12-01 | — | — | EP | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| EP-2141214-A2 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2010-01-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | RPL36, RPL39, RPL36A | CTDSP1 2078/4885PDK2 3608/4885PGR 2458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.